Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 450 participants.

Also called NCT07342608

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 450 participants (planned count) (from the registry)
Sponsor
  • MicroPort CRM Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07342608
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium, France, Italy, Portugal, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07342608. Allocation not applicable; no masking; primary purpose treatment. Start 2026-06-23 (actual); primary completion 2027-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum
Acronym
STARLIGHT
Condition
Bradycardia
Condition
Left Bundle Branch Area Pacing
Condition
Left Bundle Branch Pacing
Intervention (Device)
Use of LINEA cardiac pacing lead
Lead sponsor
MicroPort CRM (class: industry)

Record details

Record id
cardio:ct-nct07342608
Content hash
5ad434cf08c06cf15cbd266567b533e510ea06b2bbb151e8c3d2be291497d6a0